Back to Search
Start Over
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
- Source :
- Haematologica, Vol 109, Iss 1 (2023)
- Publication Year :
- 2023
- Publisher :
- Ferrata Storti Foundation, 2023.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 03906078 and 15928721
- Volume :
- 109
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Haematologica
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4917574fe414e708d9135d90b9b085d
- Document Type :
- article
- Full Text :
- https://doi.org/10.3324/haematol.2022.282469